You’ll get an insider’s market expertise combined with the objectivity of an outsider for the best possible insight into the pathology market’s competitive dynamics.
With this special report, you can tap into 100+ pages of proprietary market research:
- More than 60 charts and graphs
- Industry size and growth rates
- Medicare claims data for key pathology codes
- In-office histology lab trends
- Digital pathology market developments
- Projections for the U.S. anatomic pathology market
- Profiles of 10 public pathology companies
Only $550, (or $450 for Laboratory Economics’ subscribers)
This new research report from LABORATORY ECONOMiCS will keep you up-to-date on the fast changing business of pathology.
Ongoing consolidation, pharmacogenomics, new managed care contracting efforts, physician-office histology labs, and digital pathology are reshaping how pathology groups and labs do business. Constant change means constant decisionmaking. Choosing the best path to the future depends on two critical factors: quality of information and insightful analysis.
The U.S. Anatomic Pathology Market: Forecast & Trends 2011 includes data gathered the old-fashioned way – through primary research. The estimates and market analysis in the report have been built from the ground up. Proprietary surveys and extensive interviews with pathology groups, commercial lab executives, hospital lab directors, and respected consultants form the basis of this report. And no stone has been left unturned in our examination of the CLIA database, Medicare test volume and expenditure reports, Securities & Exchange Commission filings and company annual reports.
1: Anatomic Pathology Market Size & Structure
□ Anatomic Pathology Market Size
□ Test Volume Growth for Anatomic Pathology
□ Anatomic Pathology Company Market Share
□ Top 50 Independent Histology Labs
□ Average Annual Collected Revenue per Pathologist
□ Revenue for Subspecialties in the Pathology Market
□ Estimated New Cancer Cases, 2007-2010
2: Medicare Claims Trends
□ Medicare Reimbursement History for CPT 88305
□ Medicare Reimbursement for Key Codes in 2011
□ Reimbursement Changes for UroVysion
□ Submitted Claims Volume from 2000-2009 for
CPT 88305, 88342, 88185, 88367, 88312,
88307, 88112, 88313, 88304, 88361
□ Market Share Changes for Key CPT Codes
3: The Cervical Cancer Screening Market
□ Lab Service Revenues from Cervical Cancer Screening
□ Medicare Reimbursement for Pap Testing
□ U.S. Sales of Gardasil
□ Deaths from Cervical Cancer, 1998-2009
4: In-Office AP Laboratories
□ Number of Urology Groups Starting In-Office Labs
□ Medicare Reimbursement for Colonoscopy with Biopsy
□Number of Gastroenterology Groups Starting In-Office Labs
□ Profiles of 31 Specialty Groups that Insourced Pathology
□ List: 101 Specialty Groups with In-Office Labs
□ In-Office AP Labs Effect on Pathology Groups
□ Compensation: Urologists vs. Pathologists
5: Mergers & Acquisitions
□ Quest and LabCorp Cash Payments for Acquisitions
□ Average Purchase Price to Revenue Multiples
□ Laboratory Acquisition Summary, 2007-2010
□ Aurora Diagnostics Acquisition Summary
6: Digital Pathology
□ Percentage of Pathology Groups Using Digital Pathology
□ How Labs Are Using Digital Pathology
□ Why Some Labs Don’t Use Digital Pathology
□ U.S. Market Size for Digital Pathology
□ Medicare Claims for CPT 88361 for 2009
□ Vendor Market Share for Digital Pathology
7: The Business Outlook for Anatomic Pathology
□ Anatomic Pathology Market Size, 2010-2015
□ Fastest-Growing Subspecialties in Pathology
□ Biggest Challenges Facing Pathology Groups
□ Managed Care Reimbursement for Key Codes
□ APF Survey Results on In-Office Histology Labs
□ Competitiveness of Quest and LabCorp
□ Pharmacogenomics in Cancer Treatment
Appendix: Pathology Lab Company Profiles
Agendia, Aurora Diagnostics, Bio-Reference Labs,
Bostwick Labs, Caris Life Sciences, CBLPath,
Clarient Inc., Genomic Health, Genoptix, Genzyme
Genetics, HealthTronics/ClariPath, LabCorp,
med fusion, Myriad Genetics, NeoGenomics,
PathGroup, Quest Diagnostics
